LAVA Therapeutics Announces Pricing of Initial Public Offering
UTRECHT, The Netherlands and PHILADELPHIA, March 24, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics B.V. (Nasdaq:…
Month: March 2021
Myriad Genetics Receives Additional Reimbursement for myChoice® Diagnostic System in Japan
Comprehensive Test Helps Identify Women with Advanced Ovarian Cancer Who May Benefit from First-Line Lynparza®…
Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy
LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) – Seraph Research Institute (SRI)…
Bioasis Technologies Inc. Confirms TSXV Approval of Warrant Extension and Repricing
NEW HAVEN, Conn., March 24, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF;), (“Bioasis” or…
Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, M.D., to Board of Directors
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
iTeos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
– Initial data from Phase 1/2a trial of EOS-448 to be presented at American Association…
Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
2020 marked a year of successful evolution to a chemoprotection oncology company focused on fundamentally…
Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021
BRIDGEWATER, N.J., March 24, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
AgraFlora Provides Dial-In Information for Annual General Meeting and Business Update Presentation
VANCOUVER, British Columbia, March 24, 2021 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or…
Mustang Bio Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of…
MediWound Hosting Analyst Day Webinar on EscharEx – Enzymatic Debridement Agent for Chronic Wounds
Webinar To Be Held on Tuesday, March 30th at 10am Eastern Time YAVNE, Israel, March…
Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
Cash runway into the second half of 2023 Announced positive interim data from EQUATE study…
89bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
– Initiation of BIO89-100 Phase 2b NASH trial planned in 1H21 – – NASH histology…
TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
MALVERN, Pa., March 24, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Fourth patient treated in pivotal Phase 3 VIITAL™ study of EB-101 in RDEB after successful…
Galapagos appoints Bart Filius as President and Chief Operating Officer
Mechelen, Belgium; 24 March 2021; 21.01 CET; Galapagos (Euronext & Nasdag; GLPG) announced today that…
Guerbet: 2020 annual results
2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current…
Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
03_24 PR Image The 3 Distinct Tauri-Pet™ SKUs Commercial Launch of Tauri-Pet™ Product Line is…
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients…